SPGNY — Springer Nature AG & Co. KGaA/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2042556 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2025 | — | — | — | — | 5,098,500,000 | 302,200,000 | 3,264,500,000 |
| Dec 2024 | — | — | — | — | 5,388,600,000 | 300,100,000 | 3,574,600,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-404,200,000
Inventory
$32,100,000
Receivables
—
ST Investments
$39,000,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,926,400,000
EBITDA
$708,800,000
Free Cash Flow
$295,137,504
Enterprise Value
$3,435,251,200
Total Cash
$269,700,000
Total Debt
$1,510,099,968
Shares Out
198,888,989
Trailing EPS
$0.95
Book Value
$5.97
ROE
18.5%
ROA
5.6%
Div Yield
4.43%
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 1,847,100,000 | 404,400,000 | 68,300,000 | 5,388,600,000 | 3,574,600,000 | — | 531,200,000 |
| Dec 2023 | 1,853,000,000 | 405,600,000 | 15,500,000 | 5,411,200,000 | 5,373,200,000 | — | 491,900,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRUST | $688.88B | $750.59 | — |
| KLAC | KLA CORP | $262.74B | $2011.39 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $235.62B | $250.69 | — |
| KXIAY | Kioxia Holdings Corporation/ADR | $231.81B | $42.45 | — |
| SMEGF | Siemens Energy AG/ADR | $180.38B | $212.00 | — |
News headlines (Yahoo Finance, 1h cache)
Springer Nature AG & Co. KGaA (ETR:SPG) Passed Our Checks, And It's About To Pay A €0.83 Dividend
2026-05-24 08:43 · Yahoo
European Dividend Stocks To Enhance Your Portfolio
2026-04-21 10:32 · Yahoo
Springer Nature's CFO to Leave the Company by the end of 2026
2026-04-01 21:26 · Yahoo
Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease
2026-03-23 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.